Complete News World

Hope in Science: Cancer patients cured in new US clinical trial

Hope in Science: Cancer patients cured in new US clinical trial

A drug, given for six months, successfully cured 12 patients diagnosed with cancer of the colon and rectum. Dostarlimab, a drug that works through immunotherapy and is currently used to treat uterine cancerAnd the It was used in a small US clinical trial and demonstrated that it can put both types of cancer into remission. Patients took the drug every three weeks for six months and then had surgery and chemotherapy. But after conducting several examinations, the doctors found out that the malignant tumors had disappeared. Two years later, patients are still healthy. This study has now been published in New England Journal of Medicine.

“This is the first time since the discovery of cancer that something like this has happened,” he said. New York times Luis Diaz, one of the researchers and an oncologist at Memorial Sloan Kettering Cancer Center in New York.

Not only was the drug effective in treating cancer, it also didn’t cause any side effects in 12 patients who took part in the study. However, experts say the research has been too small to accurately determine the side effects the drug can cause.

Although promising, researchers will have to do more tests, with more patients, to get approval for the drug and confirm that it can effectively treat colorectal cancer.

See also  Janssen: Learn more about the vaccine expected to vaccinate 30-44-year-olds in Ceará | Ciara - Latest news from Ciara